Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | TEAD1 | P28347 | 1/20 | 0.37 |
| ▸ | YAP1 | P46937 | 1/20 | 0.37 |
| ▸ | TEAD4 | Q15561 | 1/20 | 0.37 |
| ▸ | TEAD2 | Q15562 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | FAAH | O00519 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7402671 | 1.00 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2CA12CA1CA2 | |
| SCHEMBL11028511 | 0.86 | CYP1A2 (0.49) | ALDH1A1SMN1; SMN2CYP1A2CYP2D6CYP3A4 | |
| SCHEMBL30649081 | 0.85 | ALDH1A1 (0.65) | ALDH1A1SMN1; SMN2TEAD1YAP1TEAD4 | |
| Hydrochloric Acid SCHEMBL5041929 | 0.84 | CYP3A4 (0.50) | ALDH1A1SMN1; SMN2CYP1A2CYP2D6CYP3A4 | |
| SCHEMBL4461350 | 0.81 | NPC1 (0.41) | ALDH1A1SMN1; SMN2EPHX2CYP2D6KMT2A | |
| SCHEMBL873911 | 0.80 | DNM1 (0.55) | ALDH1A1SMN1; SMN2CA12CA1CA2 | |
| SCHEMBL5533465 | 0.80 | ALDH1A1 (0.72) | ALDH1A1SMN1; SMN2TEAD1YAP1TEAD4 | |
| SCHEMBL29726044 | 0.79 | CA12 (0.41) | ALDH1A1SMN1; SMN2CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL1612682 | 0.78 | DNM1 (0.53) | ALDH1A1SMN1; SMN2CA12CA1CA2 | |
| SCHEMBL11125181 | 0.78 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2TEAD1YAP1TEAD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4010352-A1 | A METHOD FOR MODIFICATION OF PEPTIDES IMMOBILIZED ON A SOLID SUPPORT BY TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES | Belyntic GmbH (DE) | 2022-06-15 | — | — | EP | claimed |
| EP-0804481-B1 | SOMATOSTATIN DERIVATIVES AND THEIR RADIOLABELLED PRODUCTS | DIATIDE INC (US) | 2003-04-16 | — | — | EP | claimed |
| US-6056940-A | TECHNETIUM-99M COMPLEXING MOIETY COVALENTLY LINKED TO A PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR BINDING MOIETY HAVING A MOLECULAR WEIGHT OF LESS THAN 10,000 DALTONS | DIATIDE, INC. (US) | 2000-05-02 | — | — | US | claimed |
| WO-1994023758-A1 | RADIOLABELED COMPOUNDS FOR THROMBUS IMAGING | DIATECH, INC. (US) | 1994-10-27 | — | — | WO | claimed |
| EP-4595982-A1 | MONOCONJUGATES AND THEIR PROCESS OF PREPARATION | Syndivia (FR) | 2025-08-06 | — | — | EP | disclosed |
| WO-2025040878-A1 | COMPUTER IMPLEMENTED METHOD | BICYCLETX LIMITED (GB) | 2025-02-27 | — | — | WO | disclosed |
| EP-4010352-B1 | A METHOD FOR MODIFICATION OF PEPTIDES IMMOBILIZED ON A SOLID SUPPORT BY TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES | GYROS PROTEIN TECH AB (SE) | 2023-10-18 | — | — | EP | disclosed |
| US-20230033370-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR IL-17 | BICYCLETX LIMITED (GB) | 2023-02-02 | — | — | US | disclosed |
| US-20230033370-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR IL-17 | BICYCLETX LIMITED (GB) | 2023-02-02 | — | — | US | disclosed |
| EP-4077352-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR IL-17 | BicycleTX Limited (GB) | 2022-10-26 | — | — | EP | disclosed |
| EP-4010352-A1 | A METHOD FOR MODIFICATION OF PEPTIDES IMMOBILIZED ON A SOLID SUPPORT BY TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES | Belyntic GmbH (DE) | 2022-06-15 | — | — | EP | disclosed |
| US-11241473-B2 | Bicyclic peptide ligands and uses thereof | BICYCLETX LIMITED (GB) | 2022-02-08 | — | — | US | disclosed |
| US-20210046145-A1 | BICYCLIC PEPTIDE LIGANDS AND USES THEREOF | BICYCLETX LIMITED (GB) | 2021-02-18 | — | — | US | disclosed |
| US-10857196-B2 | Bicyclic peptide ligands and uses thereof | BICYCLETX LIMITED (GB) | 2020-12-08 | — | — | US | disclosed |
| US-10857196-B2 | Bicyclic peptide ligands and uses thereof | BICYCLETX LIMITED (GB) | 2020-12-08 | — | — | US | disclosed |
| US-20180311300-A1 | BICYCLIC PEPTIDE LIGANDS AND USES THEREOF | BICYCLETX LIMITED (GB) | 2018-11-01 | — | — | US | disclosed |
| EP-0772459-B1 | TECHNETIUM-99m LABELED IMAGING AGENTS | DIATIDE INC (US) | 2003-03-19 | — | — | EP | disclosed |
| EP-0693941-B1 | RADIOLABELED COMPOUNDS FOR THROMBUS IMAGING | DIATIDE INC (US) | 2002-07-24 | — | — | EP | disclosed |
| US-6056940-A | TECHNETIUM-99M COMPLEXING MOIETY COVALENTLY LINKED TO A PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR BINDING MOIETY HAVING A MOLECULAR WEIGHT OF LESS THAN 10,000 DALTONS | DIATIDE, INC. (US) | 2000-05-02 | — | — | US | disclosed |
| WO-1994023758-A1 | RADIOLABELED COMPOUNDS FOR THROMBUS IMAGING | DIATECH, INC. (US) | 1994-10-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10857196-B2 | Bicyclic peptide ligands and uses thereof | VIP, NGLY1, BID | ALDH1A1 4861/4885SMN1; SMN2 4460/4885CA12 741/4885 |
| US-20180311300-A1 | BICYCLIC PEPTIDE LIGANDS AND USES THEREOF | VIP, NGLY1, BID | ALDH1A1 4861/4885SMN1; SMN2 4460/4885CA12 741/4885 |
| US-20210046145-A1 | BICYCLIC PEPTIDE LIGANDS AND USES THEREOF | VIP, NGLY1, BID | ALDH1A1 4861/4885SMN1; SMN2 4460/4885CA12 741/4885 |
| US-20230033370-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR IL-17 | IL17A, IL23R, IL15 | ALDH1A1 3218/4885SMN1; SMN2 4192/4885CA12 2889/4885 |
| US-11241473-B2 | Bicyclic peptide ligands and uses thereof | VIP, NGLY1, BID | ALDH1A1 4861/4885SMN1; SMN2 4460/4885CA12 741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.